The current board are not draining the company of cash or living the high life on directors' fees and they are looking to keep the dream alive in the biomedical space. The only idea that the pretenders have is one big one: to smash and grab.
Here is a true story that points the way to supporting the current board and its plans. There once was a company called Metabolic Pharmaceuticals. It too had a marvellous biologic that had the potential to make lots of money. It was a pharmaceutical that was thought to shed unwanted fat. Like Factor, they did a well-designed clinical trial that showed no effect. And like Factor is doing now, when all hope was thought lost, it acquired another opportunity with its remaining cash. The company is now called Polynovo, shares that were once sold for just a couple of cents are now trading at over 70cents and the market cap is just under $500 million. It now has a product with FDA approval and being sold in the USA. And it is just at the beginning. It has taken 12 years but it has been worth the wait.
Factor Therapeutics might be like Metabolic P., if given the chance, and become a successful biotech company that has rises from the ashes.
Don't throw what's left away out of spite, letting the Western Australian's wolves gobble it up. Go for hope grounded on reason.
FTT Price at posting:
0.4¢ Sentiment: Hold Disclosure: Held
